| Financial Year |
March 31 2023 |
| Monetary Funds |
182,268,928.93 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
75,477,051.26 |
| Advances to Suppliers |
12,082,271.25 |
| Other Receivables |
50,299,722.05 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
183,031,248.21 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
100,203,091.04 |
| Total Current Assets |
603,362,312.74 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
23,612,361.42 |
| Fixed Assetes |
29,343,951.96 |
| Under-construction Projects |
647,660.67 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
28,685,508.68 |
| R&D expenses |
-- |
| Goodwill |
14,793,904.12 |
| Long-Term Deferred and Prepaid Expenses |
35,240,223.64 |
| Deferred Income Tax Assets |
37,598,452.93 |
| Other Non-Current Assets |
906,174.52 |
| Sub-Total of Non-Current Assets |
486,269,211.10 |
| Total Assets |
1,089,631,523.84 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
66,839,228.45 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
20,219,200.90 |
| Taxes Payable |
22,771,196.24 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
27,652,834.06 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
89,908,246.15 |
| Other Current Liabilities |
1,053,022.93 |
| Sub-Total of Current Liabilities |
243,843,676.73 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
35,371,924.54 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
99,370,550.05 |
| Total Liabilities |
343,214,226.78 |
| Paid-In Capital(Or Share Stock) |
173,273,648.00 |
| Capital Surplus |
250,478,400.33 |
| Surplus Reserve |
57,941,602.30 |
| LESS:Treasury Stock |
8,674,792.00 |
| Undistributed Profits |
250,129,815.22 |
| Minority Stockholder's Interest |
21,535,237.02 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
724,882,060.04 |
| Owner's Equity（Stockholder's Equity） |
746,417,297.06 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,089,631,523.84 |
